GVHD

Explore the most recent clinical developments in graft-versus-host disease (GVHD). Cancer Nursing Today provides up-to-date coverage of biomarkers for GVHD, chronic GVHD flares during immunosuppressive therapy, and more. From disease prevention in pediatric patients to drug evaluation for chronic GVHD, learn more about the evolution of GVHD care and research.

Study Identifies Novel Domains for Cutaneous Chronic GVHD Patient-Reported Outcome Measures
A recent study published in JAMA Dermatology identified health-related quality-of-life (HRQOL) domains for patients with cutaneous chronic graft-vs-host disease (cGVHD) that are not represented in existing GVHD- or dermatology-specific patient-reported outcome measures. The study was conducted by Emily Baumrin, MD, MSCE, and colleagues, of the University of Pennsylvania. The researchers aimed to “perform a concept elicitation study to define HRQOL in cutaneous chronic GVHD from the patient perspective and to compare experiences of patients with epidermal vs sclerotic disease.” ...
Advertisement

Knowledge Hubs

Best Practices
Best Practices

Trending

Advertisement
Expert Contributor

Advertisement
Latest News